These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9515777)

  • 1. The anti-inflammatory properties of antithrombin III: new therapeutic implications.
    Okajima K; Uchiba M
    Semin Thromb Hemost; 1998; 24(1):27-32. PubMed ID: 9515777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation.
    Okajima K
    Blood Coagul Fibrinolysis; 1998 Apr; 9 Suppl 2():S25-37. PubMed ID: 9662467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III.
    Uchiba M; Okajima K
    Semin Thromb Hemost; 1997; 23(6):583-90. PubMed ID: 9469634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin III in animal models of sepsis and organ failure.
    Dickneite G
    Semin Thromb Hemost; 1998; 24(1):61-9. PubMed ID: 9515781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are there certified indications for the use of antithrombin III in intensive care].
    Kulka PJ; Tryba M; Lange S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):143-53. PubMed ID: 11324345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure.
    Eisele B; Lamy M
    Semin Thromb Hemost; 1998; 24(1):71-80. PubMed ID: 9515782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?].
    Imberti D
    Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin: facts and new hypotheses.
    Risberg B
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S3-6. PubMed ID: 10102492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of multiple organ failure].
    Sakon M; Kambayashi J
    Nihon Rinsho; 1993 Jan; 51(1):107-13. PubMed ID: 8381881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: concerted effect with antithrombin.
    Kamikubo Y; Hamuro T; Matsuda J; Shinya N; Miyamoto S; Funatsu A; Kato H
    Thromb Haemost; 1996 Oct; 76(4):621-6. PubMed ID: 8903006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats.
    Uchiba M; Okajima K; Murakami K; Nawa K; Okabe H; Takatsuki K
    Thromb Haemost; 1995 Nov; 74(5):1265-70. PubMed ID: 8607107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
    Harada N; Okajima K; Uchiba M
    Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of multiple organ failure in critically ill newborns under AT III substitution.
    Nováková D; Simák J; Janota J; Stranák Z
    Sb Lek; 2000; 101(2):143-8. PubMed ID: 11048489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.